https://www.selleckchem.com/pr....oducts/Adriamycin.ht
Despite only 57% amino acid sequence identity, the Ab from a MARV-naïve donor recognized MARV GP and possessed neutralizing activity against the virus. Crystallization of both chimeric and full-length native heavy chain-containing Abs provided structural insights into the mechanism of binding for these types of Abs. Our work suggests that the MARV GP RBS is a promising candidate for epitope-focused vaccine design to induce neutralizing Abs against MARV.Many animals, and an increasing number of artificial agents, display sophisticated
Me gusta
Comentario
Compartir
